This investment will allow Voltea to accelerate commercialization of its membrane capacitive deionization (CapDI) technology in the global industrial and commercial water treatment markets, as well as the residential water softener market. The capital will be used to hire engineering and sales talent, and to bring online an automated, robotic module assembly facility.
Voltea’s CEO L Bryan Brister said: “Voltea is extremely excited by this investment and the expertise of our investor syndicate. The industry has been transitioning from validating whether CapDI works, to accepting and implementing it in a broad array of applications. As a result, Voltea has entered an exciting time of commercial expansion where our manual production capacity has been outstripped by market demand. We will use this capital to further expand and strengthen our global sales team, extend engineering depth and increase production capacity.”
In addition to its existing consortium of investors supporting the round, Voltea has a new investor - Anterra Capital.
“We are excited to support the further growth of Voltea investing alongside Rabobank, ETF and Unilever. We have known Voltea for many years and are impressed by the accelerated commercial progress they’ve made over the past 18 months. Water scarcity is a huge issue for the agricultural sector, with agriculture accounting for more than 70% of fresh water withdrawals. Voltea’s CapDI systems have been proven in multiple applications to be the lowest cost and most sustainable water treatment solution. That combination is great for the world, and a great investment for Anterra Capital,” said Adam Anders, managing partner at Anterra Capital.